Literature DB >> 9890323

Serum cystatin C as a determinant of fasting total homocysteine levels in renal transplant recipients with a normal serum creatinine.

A G Bostom1, R Y Gohh, L Bausserman, D Hakas, P F Jacques, J Selhub, L Dworkin, I H Rosenberg.   

Abstract

Serum creatinine, a surrogate for both renal function and homocysteine generation, is an important determinant of fasting plasma total homocysteine levels in stable renal transplant recipients. In this study, it is hypothesized that among stable renal transplant recipients with normal creatinine levels (i.e., < or = 1.5 mg/dl), serum cystatin C, a more sensitive indicator of GFR, would better predict fasting total homocysteine levels compared with serum creatinine. Fasting plasma total homocysteine, folate, vitamin B12, and pyridoxal 5'-phosphate levels, along with serum cystatin C, creatinine, and albumin levels, were determined in 28 consecutive renal transplant recipients (mean age 47 +/- 14 yr; 60.7% men) with stable allograft function, whose serum creatinine was < or = 1.5 mg/dl. General linear modeling with analysis of covariance revealed that serum cystatin C was independently predictive (partial R = 0.494; P = 0.023) of fasting total homocysteine levels after adjustment for age, gender, vitamin status, albumin, and creatinine levels. In contrast, creatinine levels were not predictive of fasting total homocysteine levels in this model (P = 0.110) or an identical model that excluded cystatin C (P = 0.131). Serum cystatin C levels may reflect subtle decreases in renal function that independently predict fasting total homocysteine levels among stable renal transplant recipients with a normal serum creatinine.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9890323     DOI: 10.1681/ASN.V101164

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  8 in total

1.  The homocysteine paradox.

Authors:  Roman N Rodionov; Steven R Lentz
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-06       Impact factor: 8.311

2.  Hyperhomocysteinaemia as a potential marker of early renal function decline in middle-aged Asian people without chronic kidney disease.

Authors:  Young Jin Tak; Dong Wook Jeong; Yun Jin Kim; Sang Yeoup Lee; Jeong Gyu Lee; Sang Heon Song; Kwang Soo Cha; Yang Ho Kang
Journal:  Int Urol Nephrol       Date:  2016-01-02       Impact factor: 2.370

3.  Cystatin C--a paradigm of evidence based laboratory medicine.

Authors:  Janice S C Chew; Mohammed Saleem; Christopher M Florkowski; Peter M George
Journal:  Clin Biochem Rev       Date:  2008-05

4.  The effect of L-arginine and creatine on vascular function and homocysteine metabolism.

Authors:  Eiman Jahangir; Joseph A Vita; Diane Handy; Monica Holbrook; Joseph Palmisano; Ryan Beal; Joseph Loscalzo; Robert T Eberhardt
Journal:  Vasc Med       Date:  2009-08       Impact factor: 3.239

5.  Elevated plasma homocysteine is positively associated with age independent of C677T mutation of the methylenetetrahydrofolate reductase gene in selected Egyptian subjects.

Authors:  Mohamed El-Sammak; Mona Kandil; Safaa El-Hifni; Randa Hosni; Mahmoud Ragab
Journal:  Int J Med Sci       Date:  2004-10-12       Impact factor: 3.738

6.  Relationship between total homocysteine, total cholesterol and creatinine levels in overt hypothyroid patients.

Authors:  Saleh A Bamashmoos; Mohammed Ak Al-Nuzaily; Ali M Al-Meeri; Faisal Hh Ali
Journal:  Springerplus       Date:  2013-08-30

Review 7.  Cystatin C--properties and use as diagnostic marker.

Authors:  A O Grubb
Journal:  Adv Clin Chem       Date:  2000       Impact factor: 5.394

8.  Cobalamin and folate status in 6 to 35 months old children presenting with acute diarrhea in Bhaktapur, Nepal.

Authors:  Manjeswori Ulak; Ram K Chandyo; Ramesh K Adhikari; Pushpa R Sharma; Halvor Sommerfelt; Helga Refsum; Tor A Strand
Journal:  PLoS One       Date:  2014-03-03       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.